Remedy Pharmaceuticals, the developer of CIRARA (intravenous glyburide) for the treatment of Large Hemispheric Infarction ...

Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China State Key Laboratory of Medicinal Chemical Biology, Nankai ...

Glaucoma is a complex and multifactorial neurodegenerative disorder primarily characterized by the progressive loss of retinal ganglion cells (RGCs) and their axons, leading to irreversible visual ...

Inflammatory responses are closely associated with many neurologic disorders and influence their outcome. In vivo imaging can document events accompanying neuroinflammation, such as changes in blood ...

With the highest quality materials, a unique manufacturing technique and advanced sealant technology, the AlboGraft Vascular Graft ... is demonstated by itswater permeability of maximum 0.1 ...

Pycnogenol French maritime pine bark extract as part of a healthier lifestyle contributes to the reduction of high blood ...

Ocugen, Inc. (NASDAQ: OCGN) this week announced the dosing of the first patient in its Phase 1 clinical trial for OCU200, a ...

Mississauga, Ontario Tuesday, January 21, 2025, 14:00 Hrs [IST] ...